A retrospective study assessing the weight change when switched to Bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV and are virally suppressed
Latest Information Update: 18 Dec 2020
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 18 Dec 2020 New trial record
- 25 Oct 2020 Results presented at the IDWeek 2020